Position in BMRN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$275,972
-$4,140,508 QoQ
Shares Held
4,823
-93.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#396
of 561 holders
Holding Since
Dec 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Marex Group plc holds $88,179,553 across 55 Biotechnology names. BMRN ranks #32 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TGTX |
Tg Therapeutics, Inc.
|
276,178 | $15,173,219 | |
| 2 | SANA |
Sana Biotechnology, Inc.
|
3,989,100 | $13,921,959 | |
| 3 | NTLA |
Intellia Therapeutics, Inc.
|
623,600 | $10,551,312 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
170,584 | $9,303,650 | |
| 5 | DNLI |
Denali Therapeutics Inc.
|
295,631 | $7,603,629 | |
| 6 | MRNA |
Moderna, Inc.
|
88,575 | $6,202,907 | |
| 7 | QURE |
uniQure N.V.
|
81,500 | $3,753,890 | |
| 8 | ABVX |
Abivax S.A.
|
27,336 | $3,642,795 |
All Filings in BMRN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $275,972 | 4,823 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $4,416,480 | 74,314 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $1,434,698 | 26,490 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $754,628 | 13,728 | Shares | Defined | 2025-08-19 | |
| 2024-03-31 | $679,330 | 7,778 | Shares | Defined | 2026-04-02 | |
| 2023-12-31 | $392,332 | 4,069 | Shares | Defined | 2026-04-02 | |
| 2023-09-30 | $709,698 | 8,021 | Shares | Defined | 2026-04-02 | |
| 2023-06-30 | $995,346 | 11,483 | Shares | Defined | 2026-04-02 | |
| 2022-12-31 | $449,043 | 4,339 | Shares | Defined | 2026-04-02 | |
| No filing history on record for this holder in this stock. | ||||||